of all these bio-techs to ISCO. Bad News is it was still traded at $0.15, but good news is it will be a true multi-bagger. (ACUR, APRI, CVM, DVAX, OPXA, STEM, VSCI, ZLCS)
Surprised you didn't include Advanced Stem Cell (ACTC) . They are having their CC tomorrow with good news on progress of AMD therapy.